MEDICINSKI GLASNIK - Aktuelno Ljekarska komora ZE - DO kantona

14
Medicinski Glasnik, Volumen 8, Number 1, February 2011
8. Gross CP, Vogel EW, Dhond AJ, Marple CB, Edwards
R, Hauch O, Ezekowitz M. Factors influencing
physicians’ reported use of anticoagulant therapy
in nonvalvular atrial fibrillation: a cross-sectional
study. Clin Ther 2003; 25:1750–64.
9. Pattacini C,
Manotti C, Pini M, Quintavalla R,
Dettori AG. A comparative study on the quality of
oral anticoagulant therapy (warfarin versus acenocoumarol).
Thromb Haemost 1994; 71:188-91.
10. Amián A, Rodríguez JN, Muñiz R, Diéguez JC, Moreno
MV, Quesada JA, Cañavate M, Fernández-Jurado
A, Martino ML, Prados D. Comparative study of
the stability of oral anticoagulant treatments (warfarin
vs acenocoumarol). Sangre 1996; 41:9-11.
11. Kropacheva ES, Panchenko EP, Ataullakhanova
DM. Long-term application of warfarin or acenocumarol
in patients with fibrillating arrhythmia: the
effects compared. Klin Med 2005; 83:24-7.
12. Palareti G, Legnani C, Guazzaloca G, Lelia V, Cosmi
B, Lunghi B, Marchetti G, Poli D, Pengo V. Risks
factors for highly unstable response to oral anticoagulation:
a case-control study. Br J of Haematology
2005; 129:72-8.
13. Undas A, Cieśla-Dul M, Zółciński M, Tracz W.
Switching from acenocoumarol to warfarin in patients
with unstable anticoagulation and its effect on
anticoagulation control. Pol Arch Med Wewn 2009;
119:360-5.
14. Barcellona D, Vannini ML, Fenu L Balestrieri C,
Marongiu F. Warfarin or acenocoumarol: which is
better in the management of oral anticoagulants?
Thromb Haemost 1998; 80:899-902.
15. Laporte S, Quenet S, Buchmüller-Cordier A, Reynaud
J, Tardy-Poncet B, Thirion C, Decousus H, Mismetti
P. Compliance and stability of INR of two oral
anticoagulants with different half-lives: a randomised
trial. Thromb Haemost 2003; 89:458-67.
16. Lengyel M;
SPORTIF-III Altanulmány Vizsgálói.
Warfarin or acenocoumarol is better in the anticoagulant
treatment of chronic atrial fibrillation? Orv
Hetil 2004; 145:2619-21.
17. Berini OE, Alvarez PG, Onrubia AM. Comparison
of quality and hemorragic risk of oral anticoagulant
therapy using acenocoumarol versus warfarin. Med
Clin 2008; 131:96-7.
18. Markatos CN, Grouzi E, Politou M, Gialeraki A,
Merkouri E, Panagou I, Spiliotopoulou I, Travlou
A.VKORC1 and CYP2C9 allelic variants influence
acenocoumarol dose requirements in Greek patients.
Pharmacogenomics 2008; 9:1631-8.
19. Wadelius M, Chen LY, Lindh JD, Eriksson N, Ghori
MJ, Bumpstead S, Holm L, McGinnis R, Rane A,
Deloukas P. The largest prospective warfarin-treated
cohort supports genetic forecasting. Blood 2009;
113:784-92.
20. Ohno M, Yamamoto A, Ono A, Miura G, Funamoto
M, Takemoto Y, Otsu K, Kouno Y, Tanabe T, Masunaga
Y, Nonen S, Fujio Y, Azuma J. Influence of
clinical and genetic factors on warfarin dose requirements
among Japanese patients. Eur J Clin Pharmacol
2009; 65:1097-103.
21. Teichert M, Eijgelsheim M, Rivadeneira F, Uitterlinden
AG, van Schaik RH, Hofman A, De Smet PA,
van Gelder T, Visser LE, Stricker BH. A genome-wide
association study of acenocoumarol maintenance
dosage. Hum Mol Genet 2009; 18:3758-68.
22. Pasterkamp E, Kruithof CJ, Van der Meer FJM, Rosendaal
FR, Vanderschoot JPM. A model-based algorithm
for the monitoring of long-term anticoagulation
therapy. J Thromb Haemost 2005; 3:915-21.
23. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS,
Halperin JL, Lip GY, Manning WJ. Antithrombotic
Therapy in Atrial Fibrillation: American College of
Chest Physicians Evidence-Based Clinical Practice
Guidelines (8th edition). Chest 2008; 133:546-92.
24. Salem DN, O’Gara PT, Madias C, Pauker SG.
Valvular and Structural Heart Disease: American
College of Chest Physicians Evidence-Based Clinical
Practice Guidelines (8th edition). Chest 2008;
133:593-629.
25. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse
R, Rich MW, Radford MJ. Clinical classification
schemes for predicting hemorrhage: results
from the National Registry of Atrial Fibrillation
(NRAF). Am Heart J 2006; 151:713-9.
26. Olson JD, Brandt JT, Chandler WL, Van Cott EM,
Cunningham MT, Hayes TE, Kottke-Marchant K,
Makur. RS, Uy AB, Wang EC. Laboratory reporting
of the international normalized ratio: progress and
problems. Arch Pathol Lab Med 2007; 131:1641-7.
27. Parra D,
Beckey NP, Stevens GR. The effect of acetaminophen
on the international normalized ratio in
patients stabilized on warfarin therapy. Pharmacotherapy
2007; 27:675-83.
28. Benhamou Y, Le Cam-Duchez V, Schneller JM, Cailleux
N, Magne JC, Soubrane JC, Borg JY, Lévesque
H. Anticoagulation clinics for outpatients: a 5-year
experience Rev Med Interne 2009; 30:567-72.
29. Ansell J, Hollowell J, Pengo V, Martinez-Brotons F,
Caro J, Drouet L. Descriptive analysis of the process
and quality of oral anticoagulation management in
real-life practice in patients with chronic non-valvular
atrial fibrillation: the international study of anticoagulation
management (ISAM). J Thromb Thrombolysis
2007; 23:83-91.
30. Fihn SD, Gadisseur AA, Pasterkamp E, van der
Meer FJ, Breukink-Engbers WG, Geven-Boere LM,
van Meegen E, de Vries-Goldschmeding H, Antheunissen-Anneveld
I, van’t Hoff AR, Harderman D,
Smink M, Rosendaal FR. Comparison of control and
stability of oral anticoagulant therapy using acenocoumarol
versus phenprocoumon. Thromb Haemost
2003; 90:260-6.
31. Jacobs LG. Warfarin pharmacology, clinical management,
and evaluation of hemorrhagic risk for the
elderly. Cardiol Clin 2008; 26:157-67.
32. Arnsten JH, Gelfand JM, Singer DE. Determinants
of compliance with anticoagulation: a case-control
study. Am J Med 1997; 103:11-7.
33. McCormick D, Gurwitz JH, Goldberg RJ, Becker R,
Tate JP, Elwell A, Radford MJ. Prevalence and quality
of warfarin use in patients with atrial fibrillation
in the long-term care setting. Archives of Internal
Medicine 2001; 16:12458-63.
34. Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact
of adherence knowledge, and quality of life on
anticoagulation control. Ann Phamacother 2005;
39:632–6.
35. van der Meer FJM, Briët E, Vandenbrouke JP, Srámek
DI, Versluijs MHPM, Rosendaal FR. The role of compliance
as a cause of instability in oral anticoagulant
therapy. Br J Haematol 1997; 98:893-900.